相关实验视频
Updated: Sep 16, 2025
08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
67.7K
炎症性肠病中的出血学:一个病例对照研究
Zsolt Szakács1,2, Beáta Csiszár3, Mátyás Nagy4
1First Department of Medicine, Medical School, University of Pécs, H-7624 Pécs, Hungary.
Journal of clinical medicine
|July 12, 2025
概括
炎症性肠病 (IBD) 患者的红细胞聚合增加,这是静脉血栓栓塞风险的关键因素. 纤维素素水平,而不是疾病活动,预测了这种血液变化,突出了炎症和炎症.
科学领域:
- 血液学 血液学 血液学
- 胃肠病学 胃肠病学
- 血管医学 血管医学
背景情况:
- 患有炎症性肠病 (IBD) 的患者患有静脉血栓塞栓症 (VTE) 的风险更高.
- 了解导致IBD中VTE的血液病学因素对于风险分层和管理至关重要.
研究的目的:
- 为了研究IBD患者的血栓前血栓变化.
- 确定与IBD中VTE风险相关的特定血液学指标.
主要方法:
- 一项病例对照研究,将IBD患者 (性结肠炎,克罗恩病) 与非IBD对照患者进行比较.
- 测量出血学参数:血粘度 (PV),全血粘度 (WBV),红细胞聚合 (EA) 和红细胞可变性 (ED).
- 使用单变量和多变量测试进行统计分析,并根据炎症标志物和疾病活性进行调整.
主要成果:
- 与对照组相比,IBD患者表现出显著增强的红细胞聚合 (EA).
- 纤维素被确定为增强EA的最强预测因子,超过克罗恩病活动指数.
- 在对共变量进行调整后,在血粘度 (PV),全血粘度 (WBV) 或红细胞变形性 (ED) 中没有观察到群体之间的显著差异.
结论:
- 炎症性肠病与红细胞聚合的增强有关,主要是由纤维素素水平预测的.
- 炎症是IBD患者观察到的静脉血栓塞栓症风险增加的关键驱动因素.
- 这些发现强调了在IBD管理中监测血液病学参数,特别是纤维素的重要性,以减轻VTE风险.
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
332
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
332
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
426
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
426
01:30Inflammatory Bowel Disease II: Crohn's Disease
392
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
392
01:17Chronic Bowel Disorders: Introduction
541
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541
01:29Inflammatory Bowel Disease IV: Pharmacological Management
198
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
198
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
237
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
237